Paper33487592
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.
Song S and 23 others. Gut, 2021. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma. Papers, record 33487592. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33487592
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.
- PubMed
- Publication types
- Clinical Trial, Phase I, Clinical Trial, Phase II, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Phytogenic | Major topic |
| Esophageal Neoplasms | Major topic |
| Gossypol | Major topic |
| Neoplastic Stem Cells | Major topic |
| Proto-Oncogene Proteins c-bcl-2 | Major topic |
| Stomach Neoplasms | Major topic |
| Animals | |
| Apoptosis | |
| Cell Line, Tumor | |
| Disease Models, Animal | |
| Docetaxel | |
| Female | |
| Humans | |
| Male | |
| Mice | |
| Middle Aged | |
| Pilot Projects |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA160433 | NCI NIH HHS | United States | R01CA160433 | PubMed | NIH RePORTER |
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed | NIH RePORTER |
| R21 CA129906 | NCI NIH HHS | United States | R21CA129906 | PubMed | NIH RePORTER |
| R21 CA127672 | NCI NIH HHS | United States | R21CA127672 | PubMed | NIH RePORTER |
| R01 CA172741 | NCI NIH HHS | United States | R01CA172741 | PubMed | NIH RePORTER |
| R01 CA138671 | NCI NIH HHS | United States | R01CA138671 | PubMed | NIH RePORTER |
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30563933 | YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30563933 | PubMed |
| 2 | 25099446 | Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma. | J Natl Compr Canc Netw | 2014 | https://conductscience.org/library/papers/25099446 | PubMed |
| 3 | 29681456 | Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing. | Cell | 2018 | https://conductscience.org/library/papers/29681456 | PubMed |
| 4 | 29115304 | Tumour heterogeneity and resistance to cancer therapies. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/29115304 | PubMed |
| 5 | 24210755 | ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. | Mol Oncol | 2014 | https://conductscience.org/library/papers/24210755 | PubMed |
| 6 | 18836097 | AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance. | Blood | 2009 | https://conductscience.org/library/papers/18836097 | PubMed |
| 7 | 30850544 | Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/30850544 | PubMed |
| 8 | 30992437 | Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. | Nat Commun | 2019 | https://conductscience.org/library/papers/30992437 | PubMed |
| 9 | 28728163 | Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients. | Br J Cancer | 2017 | https://conductscience.org/library/papers/28728163 | PubMed |
| 10 | 25604264 | Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance. | Cancer Res | 2015 | https://conductscience.org/library/papers/25604264 | PubMed |
| 11 | 28052061 | Integrated genomic characterization of oesophageal carcinoma. | Nature | 2017 | https://conductscience.org/library/papers/28052061 | PubMed |
| 12 | 18292288 | Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma. | Blood | 2008 | https://conductscience.org/library/papers/18292288 | PubMed |
| 13 | 27654712 | Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/27654712 | PubMed |
| 14 | 27697982 | Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2016 | https://conductscience.org/library/papers/27697982 | PubMed |
| 15 | 28209166 | Intra-tumor heterogeneity from a cancer stem cell perspective. | Mol Cancer | 2017 | https://conductscience.org/library/papers/28209166 | PubMed |
| 16 | 28397828 | EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. | Nat Rev Clin Oncol | 2017 | https://conductscience.org/library/papers/28397828 | PubMed |
| 17 | 31182574 | Lineage tracing and targeting of IL17RB+ tuft cell-like human colorectal cancer stem cells. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31182574 | PubMed |
| 18 | 26822577 | Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/26822577 | PubMed |
| 19 | 23536563 | Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma. | Cancer Res | 2013 | https://conductscience.org/library/papers/23536563 | PubMed |
| 20 | 25711863 | YAP and the drug resistance highway. | Nat Genet | 2015 | https://conductscience.org/library/papers/25711863 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42788341 | Reprogramming of cell death in gastric cancer: From molecular mechanisms to therapeutic potential (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42788341 | PubMed |
| 42425097 | Molecular mechanisms, current therapeutics, and emerging strategies in esophageal cancer: A comprehensive review. | Chin Med J (Engl) | 2026 | https://conductscience.org/library/papers/42425097 | PubMed |
| 42317336 | Overcoming chemoresistance in esophageal cancer with synergistic strategies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42317336 | PubMed |
| 42065052 | Multidimensional Regulatory Network of YAP1 Driving Malignant Progression in Esophageal Cancer: Molecular Mechanisms and Targeted Therapy: A Review. | Oncol Res | 2026 | https://conductscience.org/library/papers/42065052 | PubMed |
| 41596764 | BCL-2 and BCL-xL in Cancer: Regulation, Function, and Therapeutic Targeting. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596764 | PubMed |
| 40970582 | A Critical Review on BH3 Mimetic Drugs and the Treatment of Cancer-Associated Thrombosis (CAT): A Proposed Design for a Drug Delivery System Capable of Simultaneously Targeting Tumor Cells and Activated Platelets. | Cancer Med | 2025 | https://conductscience.org/library/papers/40970582 | PubMed |
| 40678726 | Potential value and cardiovascular risks of programmed cell death in cancer treatment. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40678726 | PubMed |
| 40576138 | Decoding the role of cancer stem cells in digestive tract tumors: Mechanisms and therapeutic implications (Review). | Int J Oncol | 2025 | https://conductscience.org/library/papers/40576138 | PubMed |
| 40325218 | Clofoctol impairs the stemness of gastric cancer and induces TNF-mediated necroptosis by directly binding to RanBP2. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/40325218 | PubMed |
| 40148719 | AT101 Suppresses Gastrointestinal Stromal Tumor Growth and Promotes Apoptosis via YAP/TAZ-CCND1 and FBXW7-MCL1 Axes. | Ann Surg Oncol | 2025 | https://conductscience.org/library/papers/40148719 | PubMed |
| 40075071 | Both direct and indirect suppression of MCL1 synergizes with BCLXL inhibition in preclinical models of gastric cancer. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/40075071 | PubMed |
| 39796683 | Metabolic-Modulating Effects of Radiation: Undetectable Yet Deadly-A Review on Radiotherapy. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39796683 | PubMed |
| 39735667 | Combination of fruquintinib with venetoclax for the treatment of colorectal cancer. | Oncol Res | 2025 | https://conductscience.org/library/papers/39735667 | PubMed |
| 39621144 | Circ_0000972 Inhibits Hepatocellular Carcinoma Cell Stemness by Targeting miR-96-5p/PFN1. | Biochem Genet | 2025 | https://conductscience.org/library/papers/39621144 | PubMed |
| 39557657 | YAP acts as an independent prognostic marker and regulates growth and metastasis of gastrointestinal stromal tumors via FBXW7-YAP pathway. | J Gastroenterol | 2025 | https://conductscience.org/library/papers/39557657 | PubMed |
| 39524138 | Gastrokine 1 transferred by gastric cancer exosomes inhibits growth and invasion of gastric cancer cells in vitro and in vivo. | J Cell Commun Signal | 2024 | https://conductscience.org/library/papers/39524138 | PubMed |
| 39372401 | Lactate's impact on immune cells in sepsis: unraveling the complex interplay. | Front Immunol | 2024 | https://conductscience.org/library/papers/39372401 | PubMed |
| 38653754 | SRY-Box transcription factor 9 triggers YAP nuclear entry via direct interaction in tumors. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/38653754 | PubMed |
| 38505381 | Circular RNA hsa_circ_0051246 acts as a microRNA-375 sponge to promote the progression of gastric cancer stem cells via YAP1. | PeerJ | 2023 | https://conductscience.org/library/papers/38505381 | PubMed |
| 38397398 | The Role of Methionine Restriction in Gastric Cancer: A Summary of Mechanisms and a Discussion on Tumor Heterogeneity. | Biomolecules | 2024 | https://conductscience.org/library/papers/38397398 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33487592
GET https://conductscience.org/api/papers/v1/33487592/authors?page=2